White House cites the U.S. v. Arthrex Supreme Court case to justify a science purge, a move that has drawn scrutiny from experts. The administration says the case raises questions about the authority of the National Science Board, though some experts remain unconvinced. The U.S. v. Arthrex case, which reached the Supreme Court, centers on the extent of the National Science Board's regulatory powers. The White House has used the decision as a legal foundation for its broader science policy agenda, which includes cutting certain research programs. The Supreme Court decision in U.S. v. Arthrex was delivered recently, and the case involved the National Science Board's authority over funding allocations. The White House's statement references the ruling as a precedent for limiting the Board's influence. The implications for the energy sector remain uncertain, but the decision could influence future funding for research into drilling technologies and environmental compliance. Industry stakeholders will monitor how the policy shift affects research priorities and regulatory frameworks.